8
Total deals
$5.8B
Total value
$1.2B
Avg deal
$3.0B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Viela Bio
Viela Bio is a clinical-stage biotechnology company pioneering and advancing tre…
|
2021-02-01 | Acquisition | Complete | $3.0B | Deal → |
| 2 |
Curzion Pharmaceuticals
Curzion Pharmaceuticals is a privately held development-stage biopharma company.
|
2020-04-02 | Acquisition | Complete | — | Deal → |
| 3 |
River Vision Development
River Vision Development develops a protein therapy for the treatment of Graves’…
|
2017-05-08 | Acquisition | Complete | $145.0M | Deal → |
| 4 |
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop …
|
2016-09-12 | Acquisition | Complete | $800.0M | Deal → |
| 5 |
Hyperion Therapeutics
Hyperion Therapeutics is a biopharmaceutical company focused on creating treatme…
|
2015-05-07 | Acquisition | Complete | — | Deal → |
| 6 |
Hyperion Therapeutics
Hyperion Therapeutics is a biopharmaceutical company focused on creating treatme…
|
2015-03-30 | Acquisition | Complete | $1.1B | Deal → |
| 7 |
Vidara Therapeutics
Vidara Therapeutics Research Limited was incorporated in 2003 and is based in Du…
|
2014-03-19 | Acquisition | Complete | $660.0M | Deal → |
| 8 |
Nitec Pharma
Nitec Pharma is a pharmaceutical company that commercializes and develops medici…
|
2010-04-01 | Merge | Complete | — | Deal → |